Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTPW) FCF Margin (2022 - 2025)

Historic FCF Margin for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to 484.25%.

  • 60 Degrees Pharmaceuticals' FCF Margin rose 7685900.0% to 484.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 726.36%, marking a year-over-year increase of 1347000.0%. This contributed to the annual value of 946.69% for FY2024, which is 8675900.0% up from last year.
  • 60 Degrees Pharmaceuticals' FCF Margin amounted to 484.25% in Q3 2025, which was up 7685900.0% from 1483.62% recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' FCF Margin registered a high of 262.42% during Q4 2022, and its lowest value of 7305.38% during Q3 2023.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' median FCF Margin value was 978.31% (recorded in 2025), while the average stood at 1328.32%.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by -71236500bps in 2023, then surged by 60525500bps in 2024.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' FCF Margin stood at 262.42% in 2022, then crashed by -136bps to 95.06% in 2023, then tumbled by -613bps to 677.97% in 2024, then rose by 29bps to 484.25% in 2025.
  • Its FCF Margin was 484.25% in Q3 2025, compared to 1483.62% in Q2 2025 and 978.31% in Q1 2025.